Turenne Santé, a company specialized in health, pharma & biotechnology, agreed to acquire a minority stake in Pégase Healthcare, a oncology and hematology services provider. Financial terms were not disclosed. "We are delighted to support the entire Pegase Healthcare team in this operation and thank Dimitri Verza and his teams for their trust. Pegase Healthcare is positioned in a rapidly growing market. The strong know-how of the teams and their dynamism should make it possible to seize numerous growth opportunities, both organic and external," Paul Chamoulaud and Grégory Dupas Turenne, Health Directors.